| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/16/2002 | CA1341377C Composition and method for acceleration of clot lysis |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053758A2 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053593A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/11/2002 | WO2002053592A1 Novel polypeptide and dna thereof |
| 07/11/2002 | WO2002053582A2 Process for producing peptides by using in vitrotranscription/translation system |
| 07/11/2002 | WO2002034119A3 Vaccine immunotherapy for immune suppressed patients |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002020728A3 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001078756A3 Agent for postoperative use after the removal of bone tumours |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001040476A3 Bacillus thuringiensis toxin active against formicidae (ant) |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 07/11/2002 | WO2000077486A3 Compositions and methods for detecting treponema pallidum |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | US20020092033 Turn animal bladder into a bioreactor, for gene expression of any exogenous biomolecule such as blood clotting factors, hormones; also animal models of bladder cancer; easy to purify from urine |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091235 St - B17 serotonin receptor |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091079 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2002 | US20020090723 Generating preferential cell cultures; isolate blastocyst, culture, recover cells |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090711 Generating blood glycoprotein; obtain solution containing glycoprotein, incubate in preferential buffer, recover processed glycoprotein |
| 07/11/2002 | US20020090698 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090678 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide |
| 07/11/2002 | US20020090674 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090670 Cysteine/glycine rich peptides |
| 07/11/2002 | US20020090615 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434129A1 Degradation and detection of prion infectivity |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433430A1 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/10/2002 | EP1221489A1 Regulatory sequences functioning in filamentous fungi |
| 07/10/2002 | EP1221488A1 Stress proteins and uses therefor |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221483A1 NF-AT polypeptides and polynucleotides |
| 07/10/2002 | EP1221481A1 Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same |
| 07/10/2002 | EP1221054A1 Assays for mastitis detecting haptoglobin in milk |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220934A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/10/2002 | EP1220933A1 Purification of recombinant proteins fused to multiple epitopes |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220923A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIVES |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220912A2 Novel human membrane proteins |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220893A1 Medium for the protein-free and serum-free cultivation of cells |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220864A1 Transgenically produced fusion proteins |
| 07/10/2002 | EP0931162A4 Production of a multimeric protein by cell fusion method |
| 07/10/2002 | EP0517805B1 Identification and expression of insect steroid receptor dna sequences |
| 07/10/2002 | CN1358230A 启动子 Promoter |
| 07/10/2002 | CN1358227A Production of the lipidated form of the peptido glycon-associated lipoproteins of gram-negative bacteria |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358196A Extraction of integral membrane proteins |
| 07/10/2002 | CN1357632A Intact kinetochore protein compound and its separation method and use |
| 07/10/2002 | CN1087349C novel process for preparing N-acetyl(L)-4-cyanophenylamine Ac-(L)-phe(4-CN)-OH and N-acetyl-(L)-P-amidinophenylalantne-cyclohexylglycine-beta-(3-N-methylpyridinium)alanine Ac-(L)-pAph-Chg-palme(3)-NH2 |